Patients without standard modifiable cardiovascular risk factors (SMuRFs) who present with acute MI are at an increased risk of dying when compared with those who present with at least one risk factor ...

Patients with gout flares are at heightened risk of acute MI or stroke—above and beyond their already increased cardiovascular risk—over the following 4 to 6 months, an observational study suggests.

Please provide your email address to receive an email when new articles are posted on . Data from more than 1.3 million admissions to teaching and nonteaching hospitals show there were no differences ...

Acute Myocardial Infarction (MI) managed with thrombolysis in a Polycythemia Vera (PV) patient shows that early diagnostic ...

Please provide your email address to receive an email when new articles are posted on . Hahn and colleagues conducted the investigator-initiated, randomized FRAME-AMI trial of 562 patients with acute ...

ATLANTA -- Plasma-derived human apolipoprotein A1 (CSL112) infusions failed to improve outcomes for acute myocardial infarction (MI) patients with multivessel coronary artery disease and other ...

Seven risk factors, some modifiable and some not, accounted for the vast majority of risk for first-time acute myocardial infarction (MI) in young adults, according to a case-control study. The seven ...

Credit: Getty Images A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD. Beta blockers have long been included in the ...

In patients with acute ischemic stroke and elevated high-sensitivity cardiac troponin (hs-cTn), dynamic changes in hs-cTn are not helpful in identifying myocardial infarction (MI) or distinguishing MI ...

The study covered in this summary was published in ResearchSquare.com as a preprint and has not yet been peer reviewed. Elevated blood glucose at admission for acute myocardial infarction (MI) ...

Women—especially younger women—have greater morbidity and mortality from myocardial infarction than men. The VIRGO study involving young patients (aged 18–55 years) suggests that delay in arrival to ...